To know whether mutations in MED12 are associated with the upregulation of upstream regulators, SATB2 and NRG1 in uterine fibroids, we examined the DNA methylation and expression levels of SATB2 and NRG1 in the uterine fibroids with and without MED12 mutations. This evidence concerns the gene MED12 and uterine corpus leiomyoma.